The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and ...
In a remarkable scientific achievement that adds to Kuwait's growing list of national competencies, Dr. Nada Jassim Al-Shatti ...
If these findings are confirmed in humans, it could have implications for treating many diseases where the immune system ...
Financing will support advancement of preclinical immunology pipeline. SAN DIEGO, April 04, 2025--(BUSINESS WIRE)--RayThera, ...
Why are older people more susceptible to infections than younger people? Why do vaccinations sometimes have less of an effect ...
Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and ...
Tel Aviv University team's scNET algorithm combines data on cells with protein 'social network' to cut 'high noise' and shed ...
Having measles doesn't benefit the immune system, as some believe. Science has documented that it kills the immune cells we ...
1d
OSE Immunotherapeutics Presents Preclinical Updates in Immuno-Oncology at AACR Annual Meeting 2025 OSE-CYTOMASK®, a new CIS-Demasking 1 cytokine ...
Johnson & Johnson JNJ and Pfizer PFE are two of the world’s largest pharmaceutical companies with diversified healthcare ...
Common cold symptoms tend to affect the upper airways, like the nose, head, and throat. Learn how symptoms progress with a ...
Among patients with asthma and obesity, about a quarter of encounters include obesity management, according to a poster at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback